Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis.

Journal article

BACKGROUND: No clinical trials have assessed the effects or cost-effectiveness of sequential screening strategies to detect new cases of type 2 diabetes. We used a mathematical model to estimate the cost-effectiveness of several screening strategies. METHODS: We used person-specific data from a representative sample of the US population to create a simulated population of 325,000 people aged 30 years without diabetes. We used the Archimedes model to compare eight simulated screening strategie...

Expand abstract

Authors: Kahn, R; Alperin, P; Eddy, D; Borch-Johnsen, K; Buse, J

• Publication status: Published
• Journal: Lancet
• Volume: 375
• Issue: 9723
• Pages: 1365-1374
• Publication date: 2010-04-01
• DOI: 10.1016/s0140-6736(09)62162-0
• EISSN: 1474-547X
• ISSN: 0140-6736
• Language: English
• Keywords: Quality-Adjusted Life Years; Models, Theoretical; Hypertension; Cardiovascular Diseases; Middle Aged; Diabetes Mellitus, Type 2; Age Factors; Hyperlipidemias; Models, Statistical; Aged; Mass Screening; Stroke; Adult; Humans; Cost-Benefit Analysis